Sign in

NCT07084727Recruiting

Identifying Biomarkers for Endothelial Dysfunction in Women With Preeclampsia

Retinal Biomarkers as a Tool for Early Detection of Endothelial Dysfunction in Women With Preeclampsia

Source: ClinicalTrials.gov · Last updated 24 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Every pregnancy has a major impact on a woman's heart and blood vessels due to changes required by the body to maintain proper blood flow between mother and foetus. When the placenta does not work properly, preeclampsia can occur. An important first symptom is high blood pressure. Women who have experienced preeclampsia are at higher risk of developing blood pressure and heart problems later on. Therefore, it is very important to detect changes in the blood vessel system so that they can be treated promptly and correctly. We aim to do this by using a new, non-invasive eye test that examines the blood vessels of the retina.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
60 (estimated)
First submitted
1 Jul 2025
Start date
1 Jul 2025
Primary completion date
15 Nov 2025
Lead sponsor
University Hospital, Antwerp
NCT number
NCT07084727

What you commit to

  • Study type: Interventional
  • Planned participants: 60
  • From 1 Jul 2025 to the primary completion date, 15 Nov 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • (gestational) Diabetes
  • Kidney disease
  • Auto-immune disorders
  • Connective tissue diseases

Other

  • Unwilling to provide informed consent
  • Open-angle glaucoma
  • Epilepsia
  • Multiple pregnancies
  • Fetal malformations
  • Hypercholesterolemia

Who the study is looking for

  • at least 18 years old
  • willing to undergo vascular assessments
  • informed consent signed

Age in the registry: 18 years to 40 years · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Antwerp University Hospital
Coordinator of this site? Confirm its status
EdegemBelgiumRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.